Clinical Trials Directory

Trials / Completed

CompletedNCT02467257

Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia

Potential Role of Gum Arabic as Fetal Hemoglobin Agent in Sudanese Sickle Cell Anemia Patients

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Al-Neelain University · Academic / Other
Sex
All
Age
5 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Gum Arabic is effective as fetal hemoglobin inducing agent for sickle cell anemia patients.

Detailed description

: High level of fetal haemoglobin (Hb F) decreases sickle cell anaemia (SCA) severity and leads to improved survival. Butyrate proved to increase HbF production in vivo and in vitro studies. Nonetheless, its short half-life limited its utilization in clinical practice. Gum Arabic (GA) is edible, dried, gummy exudate from Acacia Senegal tree. GA fermentation by colonic bacteria increases serum butyrate concentrations. The investigators hypothesized regular intake of GA will increase serum butyrate level. The latter will induce fetal hemoglobin production and ameliorate patients' symptoms. 47 patients hemoglobin SS aged 5-42 years, on regular follow up in Military hospital were recruited from April 2014 to January 2015 Patients received dose of G A 30g/day for 12 weeks. Hb F, complete blood count and Erythropoietin level were measured. The main outcome of interest was the level of HbF after 12 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGum Arabicoral ingestion of 30 gram every day for 12 weeks

Timeline

Start date
2014-04-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2015-06-10
Last updated
2015-06-10

Locations

1 site across 1 country: Sudan

Source: ClinicalTrials.gov record NCT02467257. Inclusion in this directory is not an endorsement.